venBio Select Advisor as of Dec. 31, 2017
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 45 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 10.4 | $159M | 17M | 9.40 | |
| BioMarin Pharmaceutical (BMRN) | 8.7 | $133M | 1.5M | 89.17 | |
| Amicus Therapeutics (FOLD) | 8.3 | $126M | 8.8M | 14.39 | |
| Clovis Oncology | 7.9 | $121M | 1.8M | 68.00 | |
| Mirati Therapeutics | 5.3 | $80M | 4.4M | 18.25 | |
| Global Blood Therapeutics In | 4.8 | $73M | 1.8M | 39.35 | |
| Array BioPharma | 4.7 | $71M | 5.5M | 12.80 | |
| Ascendis Pharma A S (ASND) | 4.4 | $67M | 1.7M | 40.06 | |
| Avexis | 4.3 | $66M | 596k | 110.67 | |
| Horizon Pharma | 4.2 | $65M | 4.4M | 14.60 | |
| Argenx Se (ARGX) | 3.3 | $51M | 805k | 63.14 | |
| Zogenix | 3.3 | $51M | 1.3M | 40.05 | |
| Assembly Biosciences | 3.2 | $48M | 1.1M | 45.25 | |
| Dermira | 2.8 | $42M | 1.5M | 27.81 | |
| Iovance Biotherapeutics (IOVA) | 2.8 | $42M | 5.3M | 8.00 | |
| Pacira Pharmaceuticals (PCRX) | 2.5 | $39M | 849k | 45.65 | |
| Medicines Company | 2.3 | $35M | 1.3M | 27.34 | |
| Bristol Myers Squibb (BMY) | 1.8 | $28M | 456k | 61.28 | |
| Tg Therapeutics (TGTX) | 1.8 | $27M | 3.3M | 8.20 | |
| AstraZeneca (AZN) | 1.7 | $26M | 750k | 34.70 | |
| Vanda Pharmaceuticals (VNDA) | 1.4 | $21M | 1.4M | 15.20 | |
| Teligent | 1.2 | $18M | 5.0M | 3.63 | |
| Myokardia | 1.1 | $17M | 398k | 42.10 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.0 | $15M | 3.9M | 3.91 | |
| Intec Pharma | 0.7 | $11M | 2.2M | 5.15 | |
| AVEO Pharmaceuticals | 0.7 | $11M | 4.0M | 2.79 | |
| Cascadian Therapeutics | 0.6 | $9.2M | 2.5M | 3.70 | |
| Alimera Sciences | 0.5 | $8.3M | 6.2M | 1.33 | |
| Agenus | 0.5 | $8.0M | 2.4M | 3.26 | |
| BioDelivery Sciences International | 0.5 | $7.3M | 2.5M | 2.95 | |
| Apellis Pharmaceuticals (APLS) | 0.5 | $7.3M | 397k | 18.45 | |
| Newlink Genetics Corporation | 0.4 | $6.5M | 795k | 8.11 | |
| Viewray (VRAYQ) | 0.4 | $5.8M | 730k | 7.98 | |
| Catalyst Biosciences | 0.4 | $5.5M | 400k | 13.64 | |
| Viveve Med | 0.3 | $5.1M | 1.0M | 4.97 | |
| Veracyte (VCYT) | 0.3 | $4.9M | 753k | 6.53 | |
| Incyte Corporation (INCY) | 0.3 | $4.7M | 50k | 94.72 | |
| Fennec Pharmaceuticals (FENC) | 0.2 | $2.7M | 206k | 13.23 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.2 | $2.5M | 6.0M | 0.42 | |
| Cellectis S A (CLLS) | 0.1 | $2.3M | 78k | 29.15 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $1.7M | 341k | 4.91 | |
| Oncobiologics | 0.1 | $889k | 684k | 1.30 | |
| Macrogenics (MGNX) | 0.0 | $39k | 15k | 2.72 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $7.0k | 233k | 0.03 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $4.7k | 233k | 0.02 |
